Vaccine Breakthrough Infections with SARS-CoV-2 Variants
N Engl J Med
.
2021 Jul 8;385(2):e7.
doi: 10.1056/NEJMc2107808.
Epub 2021 Jun 2.
Authors
Douglas F Nixon
1
,
Lishomwa C Ndhlovu
1
Affiliation
1
Weill Cornell Medicine, New York, NY dnixon@med.cornell.edu.
PMID:
34077640
DOI:
10.1056/NEJMc2107808
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Vaccines
COVID-19*
Communicable Diseases*
Humans
SARS-CoV-2
Substances
COVID-19 Vaccines